Hovione and Laxxon partner on 3D printed pharmaceuticals
The two companies enter into a long-term partnership to advance 3D screen printing technologies for applications within the pharma industry.
The two companies enter into a long-term partnership to advance 3D screen printing technologies for applications within the pharma industry.
Amid uncertainty over the future of clinical trials in the UK, the MHRA announces that it will streamline the process of running trials to make the country a more ‘attractive destination’.
The US FDA demanded more information about the device, which would deliver ABBV-951 to patients, should the treatment be approved.